Published in Eur Urol on August 07, 2017
Structure and function of telomeres. Nature (1991) 14.82
Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet (2005) 6.85
Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res (2009) 6.42
Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst (2003) 5.09
Short telomere length, cancer survival, and cancer risk in 47102 individuals. J Natl Cancer Inst (2013) 3.92
Identification of seven loci affecting mean telomere length and their association with disease. Nat Genet (2013) 3.87
The association of telomere length and cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev (2011) 3.29
Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol (2015) 2.78
Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol (2013) 2.34
Telomere length varies by DNA extraction method: implications for epidemiologic research. Cancer Epidemiol Biomarkers Prev (2013) 2.14
Balancing instability: dual roles for telomerase and telomere dysfunction in tumorigenesis. Oncogene (2002) 1.96
Genome-wide meta-analysis points to CTC1 and ZNF676 as genes regulating telomere homeostasis in humans. Hum Mol Genet (2012) 1.77
Telomere dysfunction in peripheral lymphocytes as a potential predisposition factor for renal cancer. J Urol (2007) 1.65
A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer risk. Hum Mol Genet (2013) 1.52
LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants. Bioinformatics (2015) 1.31
Telomere length varies by DNA extraction method: implications for epidemiologic research-letter. Cancer Epidemiol Biomarkers Prev (2014) 1.24
Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study. Hum Mol Genet (2015) 1.20
Telomere length in peripheral blood predicts survival in clear cell renal cell carcinoma. Cancer Res (2009) 1.18
Risk of renal cell carcinoma in relation to blood telomere length in a population-based case-control study. Br J Cancer (2011) 1.02
Genetic variants associated with longer telomere length are associated with increased lung cancer risk among never-smoking women in Asia: a report from the female lung cancer consortium in Asia. Int J Cancer (2014) 1.01
Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study. JAMA Oncol (2017) 1.00
Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes. Hum Mol Genet (2016) 0.93
Comparison of the relative telomere length measured in leukocytes and eleven different human tissues. Physiol Res (2014) 0.93
Smoking habits and leukocyte telomere length dynamics among older adults: Results from the ESTHER cohort. Exp Gerontol (2015) 0.87
Effect of obesity on telomere length: Systematic review and meta-analysis. Obesity (Silver Spring) (2015) 0.84
A prospective study of leukocyte telomere length and risk of renal cell carcinoma. Cancer Epidemiol Biomarkers Prev (2013) 0.80
Genome-wide association study identifies multiple risk loci for renal cell carcinoma. Nat Commun (2017) 0.78
Telomerase activity in renal cell carcinoma. Cancer (1998) 0.78
Danazol Treatment for Telomere Diseases. N Engl J Med (2016) 0.75
Milk intake and risk of mortality and fractures in women and men: cohort studies. BMJ (2014) 6.87
Lung cancer susceptibility locus at 5p15.33. Nat Genet (2008) 5.99
Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur Urol (2014) 5.10
Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial. Lancet (2016) 3.06
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer. Nat Genet (2015) 3.02
A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer. Nat Genet (2014) 2.72
Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma. J Clin Oncol (2012) 2.61
The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study. Lancet Oncol (2015) 1.88
Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study. Lancet Oncol (2015) 1.77
A genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium. PLoS Genet (2011) 1.68
The relationship between sweetened beverage consumption and risk of heart failure in men. Heart (2015) 1.49
Regional geographic variations in kidney cancer incidence rates in European countries. Eur Urol (2014) 1.49
Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Nat Genet (2014) 1.41
Physical Activity and Heart Failure Risk in a Prospective Study of Men. JACC Heart Fail (2015) 1.39
Treatment of infertility does not increase the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation. Fertil Steril (2015) 1.39
Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. Nat Genet (2015) 1.34
Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. Hum Mol Genet (2014) 1.09
Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial. Lancet Oncol (2016) 1.05
Local treatments for metastases of renal cell carcinoma: a systematic review. Lancet Oncol (2014) 1.03
Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study. JAMA Oncol (2017) 1.00
The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease. Cancer Res (2014) 0.96
Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes. Hum Mol Genet (2016) 0.93
Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancer. PLoS Genet (2014) 0.93
Leukocyte telomere length in relation to pancreatic cancer risk: a prospective study. Cancer Epidemiol Biomarkers Prev (2014) 0.91
Updated EAU Guidelines for Clear Cell Renal Cancer Patients Who Fail VEGF Targeted Therapy. Eur Urol (2015) 0.91
Human Papillomavirus 16 E6 Antibodies in Individuals without Diagnosed Cancer: A Pooled Analysis. Cancer Epidemiol Biomarkers Prev (2015) 0.89
Genome-wide interaction study of smoking and bladder cancer risk. Carcinogenesis (2014) 0.87
TERT gene harbors multiple variants associated with pancreatic cancer susceptibility. Int J Cancer (2015) 0.83
Smoking and All-cause Mortality in Older Adults: Results From the CHANCES Consortium. Am J Prev Med (2015) 0.83
Diabetes mellitus and the risk of gallbladder disease: A systematic review and meta-analysis of prospective studies. J Diabetes Complications (2015) 0.83
Body mass index, abdominal fatness and the risk of gallbladder disease. Eur J Epidemiol (2015) 0.82
Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations. Cancer Res (2016) 0.82
First-line sunitinib versus pazopanib in metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur J Cancer (2016) 0.82
Clinical features of serous retinopathy observed with cobimetinib in patients with BRAF-mutated melanoma treated in the randomized coBRIM study. J Transl Med (2017) 0.81
European Association of Urology Guidelines for Clear Cell Renal Cancers That Are Resistant to Vascular Endothelial Growth Factor Receptor-Targeted Therapy. Eur Urol (2016) 0.80
Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. Int J Cancer (2014) 0.80
Updated European Association of Urology Guidelines Regarding Adjuvant Therapy for Renal Cell Carcinoma. Eur Urol (2016) 0.80
Empirical hierarchical bayes approach to gene-environment interactions: development and application to genome-wide association studies of lung cancer in TRICL. Genet Epidemiol (2013) 0.80
Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC). J Genet Genome Res (2015) 0.79
Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients. Nat Commun (2015) 0.79
Previous tonsillectomy modifies odds of tonsil and base of tongue cancer. Br J Cancer (2016) 0.79
The Role of Cytoreductive Nephrectomy: European Association of Urology Recommendations in 2016. Eur Urol (2016) 0.78
Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21. Oncotarget (2016) 0.78
KRAS mutations in blood circulating cell-free DNA: a pancreatic cancer case-control. Oncotarget (2016) 0.78
Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. J Natl Cancer Inst (2016) 0.78
Posttraumatic stress and depressive symptoms in renal cell carcinoma: association with quality of life and utility of single-item distress screening. Psychooncology (2015) 0.78
Quantification of the smoking-associated cancer risk with rate advancement periods: meta-analysis of individual participant data from cohorts of the CHANCES consortium. BMC Med (2016) 0.78
Transforming growth factor-β promotes aggressiveness and invasion of clear cell renal cell carcinoma. Oncotarget (2016) 0.78
Smoking cessation and the risk of cataract: a prospective cohort study of cataract extraction among men. JAMA Ophthalmol (2014) 0.78
Prognostic significance of non-HPV16 genotypes in oropharyngeal squamous cell carcinoma. Oral Oncol (2016) 0.77
Risk of breast cancer after a diagnosis of ovarian cancer in BRCA mutation carriers: Is preventive mastectomy warranted? Gynecol Oncol (2017) 0.77
Light-to-moderate drinking and incident heart failure - the Norwegian HUNT study. Int J Cardiol (2015) 0.77
META-GSA: Combining Findings from Gene-Set Analyses across Several Genome-Wide Association Studies. PLoS One (2015) 0.77
Systematic Review of Surgical Management of Nonmetastatic Renal Cell Carcinoma with Vena Caval Thrombus. Eur Urol (2015) 0.77
Inverse association between coffee consumption and risk of cholecystectomy in women but not in men. Clin Gastroenterol Hepatol (2014) 0.77
A Systematic Review and Meta-analysis Comparing the Effectiveness and Adverse Effects of Different Systemic Treatments for Non-clear Cell Renal Cell Carcinoma. Eur Urol (2016) 0.77
Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes. Nat Genet (2017) 0.76
Dietary exposure to polychlorinated biphenyls and risk of myocardial infarction in men - A population-based prospective cohort study. Environ Int (2015) 0.76
Circulating 25-hydroxyvitamin D3 and survival after diagnosis with kidney cancer. Cancer Epidemiol Biomarkers Prev (2015) 0.76
Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry. Hum Mol Genet (2016) 0.76
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk. PLoS One (2015) 0.76
Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk. Oncotarget (2016) 0.76
A Novel Risk Locus at 6p21.3 for Epstein-Barr Virus-Positive Hodgkin Lymphoma. Cancer Epidemiol Biomarkers Prev (2015) 0.76
Plasma microRNAs as biomarkers of pancreatic cancer risk in a prospective cohort study. Int J Cancer (2017) 0.75
Alcohol and lung cancer risk among never smokers: A pooled analysis from the international lung cancer consortium and the SYNERGY study. Int J Cancer (2017) 0.75
A systematic investigation of the contribution of genetic variation within the MHC region to HPV seropositivity. Hum Mol Genet (2015) 0.75
Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration. Oncotarget (2016) 0.75
Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk. Genet Epidemiol (2015) 0.75
Association of breast cancer risk loci with breast cancer survival. Int J Cancer (2015) 0.75
Menopausal hormone therapy and breast cancer mortality: clinical implications. Ther Adv Drug Saf (2015) 0.75
ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3). Prostate (2015) 0.75
Body mass index, abdominal fatness, fat mass and the risk of atrial fibrillation: a systematic review and dose-response meta-analysis of prospective studies. Eur J Epidemiol (2017) 0.75
Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk. Hum Mol Genet (2016) 0.75
A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC/PVT1 predicts patient outcome in two independent cohorts. Br J Haematol (2016) 0.75
Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study. PLoS One (2017) 0.75
Acrylamide and glycidamide hemoglobin adduct levels and endometrial cancer risk: A nested case-control study in nonsmoking postmenopausal women from the EPIC cohort. Int J Cancer (2015) 0.75
Examination of moderators of expressive writing in patients with renal cell carcinoma: the role of depression and social support. Psychooncology (2016) 0.75
Occupational prestige, social mobility and the association with lung cancer in men. BMC Cancer (2016) 0.75
Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors. Sci Rep (2016) 0.75